Project

General

Profile

Obj. 3: Retention and VL Sup #639

3.6: Scale up VL access to all patients on ART

Added by Gilles about 1 year ago. Updated about 1 year ago.

Status:
New
Priority:
Normal
Assignee:
-
Start date:
04/01/2023
Due date:
09/30/2023 (about 12 months late)
% Done:

0%

Estimated time:
(Total: 0.00 h)
Spent time:
(Total: 3.00 h)
Additional Details
Rate $ Hourly
Additional Assignee

Subtasks

Obj. 3: Retention and VL Sup #753: Train and mentor providers on routine VL monitoring, management of patients with detectable VL, enhanced adherence counselling, identification and management of therapeutic failure, and adequate patient and information flow for adequate second line switchNew05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #761: Organize onsite mentoring of care providers (Doctor, Major and APS) in monitoring and management of patients with low and high viral load, depending on needsNew05/01/202308/31/2023

Actions
Obj. 3: Retention and VL Sup #762: Train at the regional level care providers ( doctor, Major, APS) in monitoring and management of patients with low and high viral load, depending on needsNew05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #754: Enhance U=U messaging especially, during ART initiation, to generate demand for VLNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #763: Organize afternoon mentoring session with APS and clinicians once a month per facility with 5 staffs to ensure provision of patient education during treatment preparation for newly identified clients during morning education talks or individual discussionNew05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #764: Organize role-play between expert retention APSs (with cohorts having good viral suppression) and other APS on adherence counselling sessions, adherence evaluation. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #765: Organize monthly mentoring and supportive supervision to satelitte sites use as dispension points on U=U messages during ART dispensation New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #766: Share the produced spot videos in local languages on U=U messaging to pass through social media and Treatment Unit for a literacy campaign for all sub-groups populations using different channelsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #767: Organize and carry out joint quaterly supervision by facility staff, RTG and clinical partner to evaluate quality of services offered in facilitiesNew06/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #768: Organise a CBO/Facility quarterly regional coordination meeting in Yaounde with 37 participants in Center region and 7 in East regionNew06/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #769: Support systematic reminders calls for clients eligible to VL testing with a clinical appointment or on MMD, both at facility and CBO levelNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #770: Print U=U messaging for all facilities and CBO to support health education talks following CDC branding policiesNew05/01/202306/30/2023

Actions
Obj. 3: Retention and VL Sup #755: Mentor VL champions in supported facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #771: Identify and train VL champions in all the sites to support the care providers during the viremia clinics in generating demand for VL and display U=U messagingNew05/01/202305/31/2023

Actions
Obj. 3: Retention and VL Sup #772: Transport support to VL champion to attend viremia clinic at the all facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #756: Strengthen the collaboration with CBO for VL collection in the facility or the communityNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #773: Promote referral of clients from the community to the supported facilities for VL collectionNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #774: Share the information of eligible clients for viral load with CBOs regularly for their follow-up with the clientsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #775: Identify and train CBO staffs on viral load collection and biosecurityNew07/01/202307/31/2023

Actions
Obj. 3: Retention and VL Sup #776: Coordinate and plan VL collection days by care providers in the selected CBO New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #757: Scale up VL testing for children, adolescents, and pregnant and breastfeeding women with HIV through subpopulations monitoring and using care providers, peers and OVC partnerNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #777: Linelist to be generated by each APS of all children and adolescents, and pregnant and breastfeeding women on ART with a schedule of VL sample collection by eligibility monthlyNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #778: Provide the List of children, adolescents, pregnant and breastfeeding women eligible for viral load, enrolled in the OVC program and distribution to case workers on a monthly basisNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #779: Use of a daily monitoring VL collection tool by APS based on their daily and monthly targets for collectionNew05/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #780: Ensure APS call or visit eligible patients with future appointments to come for sample collection before their appointment date (client on MMD)New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #781: Ensure sample collection for all eligible children and adolescents on ART on their appointment dates or in their Support groupsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #782: Ensure APS engage with Viral load focal point at facility level to receive and do the triage of HVL resultsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #783: Ensure VL results once received from the reference labs and distributed by cohort are documented in the patient filesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #758: Support provision of laboratory materials and transport documentation New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #784: Provide for cryotubes, vacutainer needles, gloves, alcohol, EDTA tubes, etc…New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #785: Provide cold boxes and ice packs for viral load collection and transportation in the community New06/01/202306/30/2023

Actions
Obj. 3: Retention and VL Sup #786: Continue mentoring of APSs on viral load collection procedures and biosecruityNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #759: Strengthen lab clinic interfaceNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #787: Provide monthly airtime to VL Focal points (APS) to track results return from the bikers to the reference labsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #788: Provide a tracking logbook to bikers New04/01/202304/30/2023

Actions
Obj. 3: Retention and VL Sup #760: Ensure proper documentation of VL activities at all level and performance monitoringNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #789: Provide mentoring of care providers on documentation of VL using chart abstractionNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #790: Provide VL registers and VL Request booklet in all supported facilitiesNew04/01/202304/30/2023

Actions
Obj. 3: Retention and VL Sup #791: Conduct weekly data triangulation of source documents to ensure 100% completeness and data accuracy in all facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #792: Review (revise for site with inconsistent) site flow for viral load results documentation. New04/01/202309/30/2023

Actions

No data to display

Also available in: Atom PDF